Department of Cardiology, Erasmus Medical Centre, Rotterdam, The Netherlands.
Eur Heart J. 2011 Aug;32(16):2067-74. doi: 10.1093/eurheartj/ehr110. Epub 2011 May 28.
New-onset left bundle branch block (LBBB) and complete atrioventricular block (AV3B) frequently occur following transcatheter aortic valve implantation (TAVI). We sought to determine the timing and potential mechanisms of new conduction abnormalities (CAs) during TAVI, using the Medtronic CoreValve System (MCS).
Sixty-five consecutive patients underwent TAVI with continuous 12-lead ECG analysis. New CAs were defined by the occurrence of LBBB, RBBB, and/or AV3B after the following pre-defined time points: (i) crossing of valve with stiff wire, (ii) positioning of balloon catheter in the aortic annulus, (iii) balloon valvuloplasty, (iv) positioning of MCS in the left ventricular outflow tract (LVOT), (v) expansion of MCS, (vi) removal of all catheters. A new CA occurred during TAVI in 48 patients (74%) and after TAVI in 5 (8%). Of the 48 patients with procedural CAs, a single new CA occurred in 43 patients (90%) and two types of CAs in 5 (10%). A new LBBB was seen in 40 patients (83%), AV3B in 9 (19%), and RBBB in 4 (8%). The new CA first occurred-in descending order of frequency-after balloon valvuloplasty in 22 patients (46%), MCS expansion in 14 (29%), MCS positioning in 6 (12%), positioning of balloon catheter in 3 (6%), wire-crossing of aortic valve in 2 (4%), and after catheter removal in 1 patient (2%). Patients who developed a new CA during balloon valvuloplasty had a significantly higher balloon/annulus ratio than those who did not (1.10±0.10 vs. 1.03±0.11, P=0.030). No such relationship was found with the valve/annulus ratio.
Transcatheter aortic valve implantation with the MCS was associated with new CAs in 82% of which more than half occurred before the actual valve implantation. It remains to be elucidated by dedicated studies whether new CAs can be reduced by appropriate balloon sizing-a precept that also holds for valve size given the observed directional signal of the valve size/aortic annulus ratio.
经导管主动脉瓣置换术(TAVI)后常发生新发左束支传导阻滞(LBBB)和完全性房室传导阻滞(AV3B)。我们试图使用美敦力 CoreValve 系统(MCS)确定 TAVI 期间新传导异常(CA)的时间和潜在机制。
连续 65 例患者接受 TAVI 并连续进行 12 导联心电图分析。新 CA 的定义为在以下预定时间点后出现 LBBB、RBBB 和/或 AV3B:(i)导丝穿过瓣膜,(ii)球囊导管定位在主动脉瓣环,(iii)球囊瓣膜成形术,(iv)MCS 定位在左心室流出道(LVOT),(v)MCS 扩张,(vi)所有导管取出。48 例患者(74%)在 TAVI 期间和 5 例患者(8%)在 TAVI 后发生新 CA。在 48 例有程序 CA 的患者中,43 例(90%)发生单一新 CA,5 例(10%)发生两种 CA。40 例(83%)出现新发 LBBB,9 例(19%)出现 AV3B,4 例(8%)出现 RBBB。新 CA 首先发生 - 按频率降序排列 - 在 22 例患者(46%)的球囊瓣膜成形术后,在 14 例患者(29%)的 MCS 扩张后,在 6 例患者(12%)的 MCS 定位后,在 3 例患者(6%)的球囊导管定位后,在 2 例患者(4%)的导丝穿过主动脉瓣后,在 1 例患者(2%)的导管取出后。在球囊瓣膜成形术中发生新 CA 的患者的球囊/瓣环比值明显高于未发生新 CA 的患者(1.10±0.10 比 1.03±0.11,P=0.030)。在瓣膜/瓣环比值中未发现与新 CA 相关的关系。
使用 MCS 的经导管主动脉瓣置换术与 82%的新 CA 相关,其中超过一半发生在实际瓣膜植入之前。通过专门的研究来阐明新 CA 是否可以通过适当的球囊尺寸来减少 - 这一原则也适用于观察到的瓣膜尺寸/主动脉瓣环比值的方向性信号的瓣膜尺寸。